Kanda N - Search Results

1

Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study.

Hagino T, Hamada R, Yoshida M, Saeki H, Fujimoto E, Kanda N. Hagino T, et al. Among authors: kanda n. Pharmaceuticals (Basel). 2024 Apr 18;17(4):519. doi: 10.3390/ph17040519. Pharmaceuticals (Basel). 2024. PMID: 38675479 Free PMC article.

2

PmrAB, the two-component system of Acinetobacter baumannii, controls the phosphoethanolamine modification of lipooligosaccharide in response to metal ions.

Yamada N, Kamoshida G, Shiraishi T, Yamaguchi D, Matsuoka M, Yamauchi R, Kanda N, Kamioka R, Takemoto N, Morita Y, Fujimuro M, Yokota S-i, Yahiro K. Yamada N, et al. Among authors: kanda n. J Bacteriol. 2024 Apr 25:e0043523. doi: 10.1128/jb.00435-23. Online ahead of print. J Bacteriol. 2024. PMID: 38661375

3

Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study.

Hagino T, Saeki H, Fujimoto E, Kanda N. Hagino T, et al. Among authors: kanda n. J Dermatolog Treat. 2024 Dec;35(1):2344591. doi: 10.1080/09546634.2024.2344591. Epub 2024 Apr 23. J Dermatolog Treat. 2024. PMID: 38653561 Free article.

4

Author reply to the letter regarding 'Dietary habits in adult Japanese patients with vitiligo'.

Hamada R, Funasaka Y, Saeki H, Serizawa N, Hagino T, Yano Y, Mitsui H, Kanda N. Hamada R, et al. Among authors: kanda n. J Dermatol. 2024 Apr 23. doi: 10.1111/1346-8138.17250. Online ahead of print. J Dermatol. 2024. PMID: 38651734 No abstract available.

5

Real-world effectiveness and safety of bimekizumab in Japanese patients with psoriasis: A single-center retrospective study.

Hagino T, Saeki H, Fujimoto E, Kanda N. Hagino T, et al. Among authors: kanda n. J Dermatol. 2024 May;51(5):649-658. doi: 10.1111/1346-8138.17186. Epub 2024 Mar 14. J Dermatol. 2024. PMID: 38482898

6

Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan.

Hagino T, Hamada R, Yoshida M, Saeki H, Fujimoto E, Kanda N. Hagino T, et al. Among authors: kanda n. Clin Drug Investig. 2024 Apr;44(4):261-269. doi: 10.1007/s40261-024-01352-4. Epub 2024 Mar 6. Clin Drug Investig. 2024. PMID: 38446396

7

Dietary habits in adult Japanese patients with vitiligo.

Hamada R, Funasaka Y, Saeki H, Serizawa N, Hagino T, Yano Y, Mitsui H, Kanda N. Hamada R, et al. Among authors: kanda n. J Dermatol. 2024 Apr;51(4):491-508. doi: 10.1111/1346-8138.17163. Epub 2024 Feb 29. J Dermatol. 2024. PMID: 38421796

8

Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan.

Hagino T, Saeki H, Fujimoto E, Kanda N. Hagino T, et al. Among authors: kanda n. J Dermatolog Treat. 2024 Dec;35(1):2307489. doi: 10.1080/09546634.2024.2307489. Epub 2024 Feb 2. J Dermatolog Treat. 2024. PMID: 38305215 Free article.

9

Okeanic acid-A, a trihydroxy fatty acid from the Okinawan cyanobacterium Okeania hirsuta.

Nishino H, Kanda N, Zhang BT, Kamio M, Uchida H, Sugahara K, Nagai H, Satake M. Nishino H, et al. Among authors: kanda n. Nat Prod Res. 2024 Feb 1:1-8. doi: 10.1080/14786419.2024.2308724. Online ahead of print. Nat Prod Res. 2024. PMID: 38300791

10

Time-domain characterization of electric field vector in multi-terahertz pulses using polarization-modulated electro-optic sampling.

Kanda N, Nakagawa M, Murotani Y, Matsunaga R. Kanda N, et al. Opt Express. 2024 Jan 15;32(2):1576-1584. doi: 10.1364/OE.506405. Opt Express. 2024. PMID: 38297706 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

422 results

Search Page